Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620707
Title:
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
Authors:
Lipson, D. A. [et al] inc.; Halpin, David M
Abstract:
The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain.
Citation:
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.
Publisher:
NEJM
Journal:
The New England journal of medicine
Issue Date:
May-2018
URI:
http://hdl.handle.net/11287/620707
DOI:
10.1056/NEJMoa1713901
PubMed ID:
29668352
Additional Links:
http://www.nejm.org/doi/abs/10.1056/NEJMoa1713901?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Type:
Journal Article; Clinical Trial, Phase III; Comparative Study; Randomized Controlled Trial
Language:
en
ISSN:
1533-4406
Appears in Collections:
Respiratory Medicine; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorLipson, D. A. [et al] inc.en
dc.contributor.authorHalpin, David Men
dc.date.accessioned2018-06-20T14:53:18Z-
dc.date.available2018-06-20T14:53:18Z-
dc.date.issued2018-05-
dc.identifier.citationOnce-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.en
dc.identifier.issn1533-4406-
dc.identifier.pmid29668352-
dc.identifier.doi10.1056/NEJMoa1713901-
dc.identifier.urihttp://hdl.handle.net/11287/620707-
dc.description.abstractThe benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain.en
dc.language.isoenen
dc.publisherNEJMen
dc.relation.urlhttp://www.nejm.org/doi/abs/10.1056/NEJMoa1713901?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmeden
dc.rightsArchived with thanks to The New England journal of medicineen
dc.subjectWessex Classification Subject Headings::Respiratory medicineen
dc.subject.meshAdministration, Inhalation-
dc.subject.meshAdrenergic beta-Agonists-
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAndrostadienes-
dc.subject.meshBenzyl Alcohols-
dc.subject.meshBronchodilator Agents-
dc.subject.meshChlorobenzenes-
dc.subject.meshDouble-Blind Method-
dc.subject.meshDrug Administration Schedule-
dc.subject.meshDrug Combinations-
dc.subject.meshDyspnea-
dc.subject.meshFemale-
dc.subject.meshGlucocorticoids-
dc.subject.meshHospitalization-
dc.subject.meshHumans-
dc.subject.meshIntention to Treat Analysis-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshMuscarinic Antagonists-
dc.subject.meshPulmonary Disease, Chronic Obstructive-
dc.subject.meshQuality of Life-
dc.subject.meshQuinuclidines-
dc.titleOnce-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.en
dc.typeJournal Articleen
dc.typeClinical Trial, Phase IIIen
dc.typeComparative Studyen
dc.typeRandomized Controlled Trialen
dc.identifier.journalThe New England journal of medicineen
dc.type.versionPublisheden
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.